Building on the seminal discovery by Sitkovsky et al. which demonstrated tumor protection by adenosine receptor A2AR activation11, CD73-mediated adenosinergic effects are now considered one of the important immunosuppressive pathways in the tumor12–17. This evidence concerns the gene NT5E and neoplasm.